Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SYH2043
i
Other names:
SYH2043, SYH-2043, SYH 2043
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CSPC Pharma
Drug class:
CDK2/4/6 inhibitor
Related drugs:
‹
culmerciclib (2)
PF-06873600 (1)
NUV-422 (0)
PF-07224826 (0)
culmerciclib (2)
PF-06873600 (1)
NUV-422 (0)
PF-07224826 (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors (NCT05728541)
Phase 1
CSPC Ouyi Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.
Not yet recruiting
Phase 1
CSPC Ouyi Pharmaceutical Co., Ltd.
Not yet recruiting
Last update posted :
02/17/2023
Initiation :
03/01/2023
Primary completion :
02/01/2026
Completion :
03/01/2026
HER-2 • ER
|
SYH2043
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.